Evaluation of slow-releasing diphenylpyraline in chronic urticaria and various kinds of dermatites.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D003872:Dermatitis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011537:Pruritus / Q000188:drug therapy; D013607:Tablets; D013997:Time Factors; D014581:Urticaria / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D006634:Histamine H1 Antagonists; D010880:Piperidines; D010919:Placebos; D013607:Tablets